Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: The US Food and Drug Administration (FDA) has approved Genentech's Perjeta for people with her2-positive met...
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...
Singapore: National Institutes of Health (NIH) Clinical Center has suspended operations of its Pharmaceutical Developmen...
Singapore: Researchers at the National Institutes of Health (NIH) have identified a potential new drug that could help i...
Singapore: Alexion pharma has announced the submission of New Drug Application (NDA) to the Japanese Ministry of Health,...
Singapore: Japanese pharma major Takeda Pharmaceutical Company has announced that the randomized, double-blind, placebo-...
Singapore: A phase II interim analysis of a randomized study involving Boehringer Ingelheim's investigational haematolog...
Singapore: Australian biotechnology company Minomic International has collaborated with US partner to develop a potentia...
Singapore: The US Food and Drug Administration (FDA) has granted Genmab and GlaxoSmithKline (GSK) breakthrough therapy d...
Singapore: According to an international multiple sclerosis (MS) registry and a US health claims database, Novartis' Gi...
Singapore: Gilead Sciences has expanded its agreement with Ireland based Janssen for the development and commercializati...
Tokyo: Shionogi, one of Japan's century-old pharmaceutical manufacturers, has announced that its once-daily naldemedine ...
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...
Singapore: Taiwan's PharmaEngine licensing partner, Merrimack Pharmaceuticals, and its sublicensing partner, Baxter Inte...
